Privia Health Group Inc

Privia Health Group Inc(PRVA)股票分析

$22.930

+0.500 (+2.18%)收盘时

Loading chart…
最高
23.130
开盘
22.650
成交量加权均价
22.89
成交量
824.63K
市值
2.04B
最低
22.600
成交额
18.87M
企业价值/息税折旧摊销前利润(TTM)
-6,436.92

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

AI 分析 of Privia Health Group Inc (PRVA)

买入

Privia Health Group Inc is a good buy right now, trading at $22.52 with a strong RSI of 86.73 indicating overbought conditions, but also reflecting strong momentum. The company reported a significant 12.4% year-over-year increase in practice collections to $970 million in Q2 2026, and raised its financial outlook for the year, which is a positive indicator for future growth. However, the main risk is the recent earnings surprise of -12.5%, which may affect investor sentiment.

估值指标

Privia Health Group Inc(PRVA)当前预期市盈率为 17.27,5 年平均预期市盈率为 59.79。

预期市盈率

合理
5 年均值 P/E
59.79
当前P/E
17.27
高估
344.17
低估
-224.59

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
-130.22
当前EV/EBITDA
-6436.92
高估
1028.72
低估
-1289.16

预期市销率

低估
5 年均值 P/S
1.60
当前P/S
1.06
高估
2.10
低估
1.10

Alphio AI 对 PRVA 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%PRVA

$29.18

情景价格

基

基准

基准 · 50%PRVA

$27.83

情景价格

悲

悲观

悲观 · 25%PRVA

$24.83

情景价格

持有 PRVA 的大户

V

Van Berkom and Associates Inc.

+ 持有PRVA

+2.18%

3个月收益率

D

Durable Capital Partners, LP

+ 持有PRVA

-3.13%

3个月收益率

事件时间线

2026-08-06 (ET)

06:30:00

Company Reports Q2 Revenue of $632.6M

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Expects Approximately $600M in Cash by Year-End 2026

资讯

PRVA 常见问题 —— 由 Alphio AI 解答

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now, trading at $22.52 with a strong RSI of 86.73 indicating overbought conditions, but also reflecting strong momentum. The company reported a significant 12.4% year-over-year increase in practice collections to $970 million in Q2 2026, and raised its financial outlook for the year, which is a positive indicator for future growth. However, the main risk is the recent earnings surprise of -12.5%, which may affect investor sentiment.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易